(GBSN) (GBSN) Stock Price, News & Analysis

Company Overview

Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.

Key Stats

• Today's Range: $0.10 to $0.12
• 50-Day Range: N/A
• 52-Week Range: $0.03 to $18.00
• Volume: 104,097 shs
• Average Volume: 99,205 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GBSN Stock Analysis - Frequently Asked Questions

How were (GBSN)'s earnings last quarter?

(GBSN) (NASDAQ:GBSN) posted its earnings results on Wednesday, March, 22nd. The medical research company reported ($18.25) earnings per share for the quarter. The medical research company had revenue of $0.85 million for the quarter.

When did (GBSN)'s stock split?

Shares of (GBSN) reverse split on Friday, September 16th 2016.The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 15th 2016. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of (GBSN) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (GBSN) investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), (BBEPQ) (BBEPQ), BioCryst Pharmaceuticals (BCRX), (UPLMQ) (UPLMQ) and VelocityShares Daily 2x VIX Short-Term ETN (TVIX).

Company Calendar

• Last Earnings: 3/22/2017
• Today: 8/05/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GBSN
• CIK: 1512138
• Web: gbscience.com
• Phone: +1-801-9901055
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A